Vor Biopharma Inc [NASDAQ: VOR] price surged by 36691984 percent to reach at $2229999.76.
The one-year VOR stock forecast points to a potential downside of -34898178.56. The average equity rating for VOR stock is currently 3.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Vor Biopharma Inc [VOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VOR shares is $6.39 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VOR stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wedbush have made an estimate for Vor Biopharma Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 26, 2022. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on April 27, 2022, representing the official price target for Vor Biopharma Inc stock. Previously, the target price had yet another raise to $26, while H.C. Wainwright analysts kept a Buy rating on VOR stock.
The Price to Book ratio for the last quarter was 0.55, with the Price to Cash per share for the same quarter was set at 0.48.
VOR Stock Performance Analysis:
Vor Biopharma Inc [VOR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 59.25. With this latest performance, VOR shares gained by 58.73% in over the last four-week period, additionally sinking by -70.30% over the last 6 months – not to mention a drop of -73.87% in the past year of trading.
Insight into Vor Biopharma Inc Fundamentals:
Return on Equity for this stock declined to -85.83%, with Return on Assets sitting at -85.83%.
VOR Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VOR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Vor Biopharma Inc go to 33.72%.
Vor Biopharma Inc [VOR] Institutonal Ownership Details
There are presently around $48.76%, or 71.59%% of VOR stock, in the hands of institutional investors. The top three institutional holders of VOR stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 22.75 million shares, which is approximately 33.439%. FMR LLC, holding 7.08 million shares of the stock with an approximate value of $$7.08 million in VOR stocks shares; and FMR LLC, currently with $$6.46 million in VOR stock with ownership which is approximately 9.4917%.
